Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID | Title ▼ | Descriptor |
|---|---|---|---|
| 7VFL | A0A0H2XGN0 | Crystal structure of SdgB (UDP, NAG, and O-glycosylated SD peptide-binding form) | |
| 7VFL | 7VFL | Crystal structure of SdgB (UDP, NAG, and O-glycosylated SD peptide-binding form) | |
| 5M93 | P0CG47 | Crystal structure of SdeA-modified ubiquitin. | |
| 8B87 | Q14160 | Crystal structure of Scribble PDZ1 with human papillomavirus strain 16 E6 peptide | |
| 8B87 | A0A384KQK8 | Crystal structure of Scribble PDZ1 with human papillomavirus strain 16 E6 peptide | |
| 5O9R | Q06135 | Crystal structure of ScGas2 in complex with compound 9 | |
| 5OA2 | Q06135 | Crystal structure of ScGas2 in complex with compound 8 | |
| 5O9Q | Q06135 | Crystal structure of ScGas2 in complex with compound 6 | |
| 3CA5 | P33183 | Crystal structure of Sambucus nigra agglutinin II (SNA-II)-tetragonal crystal form- complexed to alpha1 methylgalactose | |
| 3CA3 | P33183 | Crystal structure of Sambucus Nigra Agglutinin II (SNA-II)-tetragonal crystal form- complexed to N-Acetylgalactosamine | |
| 4GVH | Q8ZQ06 | Crystal structure of Salmonella typhimurium family 3 glycoside hydrolase (NagZ) covalently bound to 5-fluoro-GlcNAc. | Beta-hexosaminidase (E.C.3.2.1.52) |
| 4HZM | Q8ZQ06 | Crystal structure of Salmonella typhimurium family 3 glycoside hydrolase (NagZ) bound to N-[(3S,4R,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)piperidin-3-yl]butanamide | |
| 4GVF | Q8ZQ06 | Crystal structure of Salmonella typhimurium family 3 glycoside hydrolase (NagZ) bound to GlcNAc | |
| 7EZZ | P0A232 | Crystal structure of Salmonella typhi outer membrane phospholipase (OMPLA) dimer with bound calcium | |
| 6L3E | A0A0W3SG76 | Crystal structure of Salmonella enterica sugar-binding protein MalE | |
| 4WN3 | P13298 | Crystal structure of Saccharomyces cerevisiae OMP synthase in complex with PRP(NH)P | |
| 4WML | P13298 | Crystal structure of Saccharomyces cerevisiae OMP synthase in complex with PRP(CH2)P | |
| 2AJ4 | P04385 | Crystal structure of Saccharomyces cerevisiae Galactokinase in complex with galactose and Mg:AMPPNP | |
| 3WJ1 | Q5NU42 | Crystal structure of SSHESTI | Carboxylesterase (E.C.3.1.1.1) |
| 6KX1 | 6KX1 | Crystal structure of SN-101 mAb in complex with MUC1 glycopeptide | |
| 7SPR | A8PUY1 | Crystal structure of SMG1 mutant (G28C/P206C/Q34P/A37P/M176V/G177A/M294R/F278N) | |
| 4ZRD | A8PUY1 | Crystal structure of SMG1 F278N mutant | |
| 4ZRE | A8PUY1 | Crystal structure of SMG1 F278D mutant | |
| 3WMP | A4CYJ6 | Crystal structure of SLL-2 | |
| 8FBW | 8FBW | Crystal structure of SIV-1 V2 antibody NCI05 in complex with a V2 peptide | |
| 8WSP | F1BDJ0 | Crystal structure of SFTSV Gn and antibody SF5 | |
| 8WSP | 8WSP | Crystal structure of SFTSV Gn and antibody SF5 | |
| 8WSN | F1BWV6 | Crystal structure of SFTSV Gn and antibody SF1 | |
| 8WSN | 8WSN | Crystal structure of SFTSV Gn and antibody SF1 | |
| 2E50 | Q01105 | Crystal structure of SET/TAF-1beta/INHAT | |
| 6XQM | A0A0B5H9B3 | Crystal structure of SCLam E144S mutant, a non-specific endo-beta-1,3(4)-glucanase from family GH16, co-crystallized with laminarihexaose, presenting a laminaribiose and a glucose at active site | |
| 6XQH | A0A0B5H9B3 | Crystal structure of SCLam E144S mutant, a non-specific endo-beta-1,3(4)-glucanase from family GH16, co-crystallized with cellotriose, presenting a 1,3-beta-D-cellobiosyl-glucose and a cellobiose at active site | |
| 6XQL | A0A0B5H9B3 | Crystal structure of SCLam E144S mutant, a non-specific endo-beta-1,3(4)-glucanase from family GH16, co-crystallized with cellohexaose, presenting a 1,3-beta-D-cellobiosyl-glucose at active site | |
| 6XQF | A0A0B5H9B3 | Crystal structure of SCLam E144S mutant, a non-specific endo-beta-1,3(4)-glucanase from family GH16, co-crystallized with 1,3-beta-D-cellotriosyl-glucose, presenting a 1,3-beta-D-cellobiosyl-glucose at active site | |
| 6XQG | A0A0B5H9B3 | Crystal structure of SCLam E144S mutant, a non-specific endo-beta-1,3(4)-glucanase from family GH16, co-crystallized with 1,3-beta-D-cellobiosyl-cellobiose, presenting a 1,3-beta-D-cellobiosyl-glucose at active site | |
| 8H5U | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with neutralizing nanobody Nb-021 | |
| 8H5U | 8H5U | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with neutralizing nanobody Nb-021 | |
| 8H5T | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with neutralizing nanobody Nb-015 | |
| 8H5T | 8H5T | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with neutralizing nanobody Nb-015 | |
| 8SIT | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.24 Fab | |
| 8SIT | 8SIT | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.24 Fab | |
| 8SIS | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.2 Fab | |
| 8SIS | 8SIS | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.2 Fab | |
| 8SIR | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC25.54 Fab | |
| 8SIR | 8SIR | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC25.54 Fab | |
| 8SIQ | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibodies CC25.36 and CV38-142 Fab | |
| 8SIQ | 8SIQ | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibodies CC25.36 and CV38-142 Fab | |
| 6M0J | Q9BYF1 | Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2 | |
| 6M0J | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2 | |
| 7X2H | 7X2H | Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with 6-2C Fab |
